Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Efgartigimod + Telitacicept (1-week interval) group[1] Telitacicept (Telitacicept)---[1] 11 💬
2Efgartigimod + Telitacicept (2-week interval) group[1] Telitacicept (Telitacicept)---[1] 11 💬
3Telitacicept[1] Telitacicept (Telitacicept)---[14] 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
4Telitacicept 160 mg[1] Telitacicept (Telitacicept)---[1] 53 💬
5Telitacicept 160mg[1] Telitacicept (Telitacicept)---[3] 49, 66, 223 💬
6Telitacicept 240mg[1] Telitacicept (Telitacicept)---[1] 66 💬
7Telitacicept 80 mg[1] Telitacicept (Telitacicept)---[1] 53 💬
8Telitacicept Freeze-dried powder Injection 80mg[1] Telitacicept (Telitacicept)---[1] 49 💬
9Telitacicept Tofacitinib[2] Telitacicept (Telitacicept),
Tofacitinib
[2] Tofacitinib citrate ,
Tofacitinib 💬
[4] JAK1,
JAK2,
JAK3,
TYK2 💬
[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
10Telitacicept+SOC[1] Telitacicept (Telitacicept)---[1] 48 💬
11Telitacicept-only group[1] Telitacicept (Telitacicept)---[1] 11 💬